Favorite  |  Set Home
Products > Others > > Teneligliptin
Product name : Teneligliptin
Item : CR1933
Price : 500g, $845; 1g, $1485
contact : Send inquiry to: info@acesobio.com
Additional Information :  We offer significant discount for bulky quantity order,Please ask price and availability of other quantities
CAS : 760937-92-6
 Enlarge Image                   Back
←[Previous Product]              [Next Product]→


Details:
 

Chemical Information

M.Wt 426.58 Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Formula C22H30N6OS
CAS No 760937-92-6
Solubility

DMSO



Biological Activity of Teneligliptin

 

Teneligliptin is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes. Dipeptidyl peptidase-4 (DPP-4) inhibitors have been demonstrated to improve glycemic control, in particular postprandial hyperglycemic control, in patients with type 2 diabetes. Studies indicate that teneligliptin is a potent, competitive, and long-lasting DPP-4 inhibitor that improves postprandial hyperglycemia and dyslipidemia by both single and repeated administrations.

 

Clinical Information of Teneligliptin

MORE

1 . Eto T, Inoue S, Kadowaki T. Effects of once-daily teneligliptin on 24-h blood glucose control and safety in Japanese patients with type 2 diabetes mellitus: a 4-week, randomized, double-blind, placebo-controlled trial. Diabetes Obes Metab. 2012 Nov;14(11):1040-6.
Abstract
AIM: To assess blood glucose control over 24?h and the safety of teneligliptin 10 and 20?mg, a novel dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes mellitus inadequately controlled with diet and exercise. METHODS: Ninety-nine patients were administered teneligliptin 10 or 20 mg or placebo before breakfast for 4 weeks in a randomized, double-blind, placebo-controlled, parallel-group study. RESULTS: Both teneligliptin-treated groups showed significantly smaller 2-h postprandial glucose (2-h PPG), 24-h mean glucose and fasting plasma glucose values than the placebo group. The differences between the teneligliptin 10?mg and placebo groups in changes in 2-h PPG after each meal were -50.7?±?7.8, -34.8?±?9.2 and -37.5?±?7.5?mg/dl at breakfast, lunch and dinner, respectively [least-squares (LS) means?±?standard error (s.e.), all, p?
2 . Yoshida T, Akahoshi F, Sakashita H et al. Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine): A highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. Bioorg Med Chem. 2012 Oct 1;20(19):5705-19.
Abstract
Dipeptidyl peptidase IV (DPP-4) inhibition is suitable mechanism for once daily oral dosing regimen because of its low risk of hypoglycemia. We explored linked bicyclic heteroarylpiperazines substituted at the γ-position of the proline structure in the course of the investigation of l-prolylthiazolidines. The efforts led to the discovery of a highly potent, selective, long-lasting and orally active DPP-4 inhibitor, 3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine (8g), which has a unique structure characterized by five consecutive rings. An X-ray co-crystal structure of 8g in DPP-4 demonstrated that the key interaction between the phenyl ring on the pyrazole and the S(2) extensive subsite of DPP-4 not only boosted potency, but also increased selectivity. Compound 8g, at 0.03mg/kg or higher doses, significantly inhibited the increase of plasma glucose levels after an oral glucose load in Zucker fatty rats. Compound 8g (teneligliptin) has been approved for the treatment of type 2 diabetes in Japan.
3 . Fukuda-Tsuru S, Anabuki J, Abe Y et al. A novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, improves postprandial hyperglycemia and dyslipidemia after single and repeated administrations. Eur J Pharmacol. 2012 Sep 26. pii: S0014-2999(12)00798-4. doi: 10.1016/j.ejphar.2012.09.024.
Abstract
Dipeptidyl peptidase-4 (DPP-4) inhibitors have been demonstrated to improve glycemic control, in particular postprandial hyperglycemic control, in patients with type 2 diabetes. Teneligliptin is a novel chemotype prolylthiazolidine-based DPP-4 inhibitor. The present study aimed to characterize the pharmacological profiles of teneligliptin in vitro and in vivo. Teneligliptin competitively inhibited human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC(50) values of approximately 1nmol/l. Oral administration of teneligliptin in Wistar rats resulted in the inhibition of plasma DPP-4 with an ED(50) of 0.41mg/kg. Plasma DPP-4 inhibition was sustained even at 24h after administration of teneligliptin. An oral carbohydrate-loading test in Zucker fatty rats showed that teneligliptin at ≥0.1mg/kg increased the maximum increase in plasma glucagon-like peptide-1 and insulin levels, and reduced glucose excursions. This effect was observed over 12h after a dose of 1mg/kg. An oral fat-loading test in Zucker fatty rats also showed that teneligliptin at 1mg/kg reduced triglyceride and free fatty acid excursions. In Zucker fatty rats, repeated administration of teneligliptin for two weeks reduced glucose excursions in the oral carbohydrate-loading test and decreased the plasma levels of triglycerides and free fatty acids under non-fasting conditions. The present studies indicate that teneligliptin is a potent, competitive, and long-lasting DPP-4 inhibitor that improves postprandial hyperglycemia and dyslipidemia by both single and repeated administrations.


Related Products :
Traxoprodil (CP-101606)
Traxoprodil (CP-101606)
Price: 10mg, $195; 50mg, $595; 100mg, $895; 200mg, $1355
Retapamulin (SB 275833)
Retapamulin (SB 275833)
Price: 10mg, $125; 50mg, $495; 100mg, $995; 200mg, $1695
Netobimin
Netobimin
Price: 10mg, $125; 50mg, $495; 100mg, $695; 200mg, $1095
PEAQX
PEAQX
Price: 100mg, $945; 200mg, $1485
LY 2886721
LY 2886721
Price: 10mg, $275; 50mg, $845; 100mg, $1295; 200mg, $2295
CAY10650
CAY10650
Price: 50mg, $1045;100mg, $1785
Mdivi 1
Mdivi 1
Price: 500mg, $745; 1g, $1285
Bexarotene
Bexarotene
Price: 10mg, $45; 50mg, $145; 100mg, $225; 200mg, $455